| Product Code: ETC10639365 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Anti-Cancer Drug Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Anti-Cancer Drug Market Revenues & Volume, 2021 & 2031F |
3.3 China Anti-Cancer Drug Market - Industry Life Cycle |
3.4 China Anti-Cancer Drug Market - Porter's Five Forces |
3.5 China Anti-Cancer Drug Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 China Anti-Cancer Drug Market Revenues & Volume Share, By Therapy, 2021 & 2031F |
3.7 China Anti-Cancer Drug Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 China Anti-Cancer Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in China |
4.2.2 Growing awareness about cancer prevention and treatment |
4.2.3 Government initiatives to improve healthcare infrastructure and access to cancer treatment |
4.3 Market Restraints |
4.3.1 Stringent regulatory processes for drug approval |
4.3.2 High cost associated with cancer treatment and drugs |
4.3.3 Limited access to advanced cancer care facilities in rural areas |
5 China Anti-Cancer Drug Market Trends |
6 China Anti-Cancer Drug Market, By Types |
6.1 China Anti-Cancer Drug Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 China Anti-Cancer Drug Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 China Anti-Cancer Drug Market Revenues & Volume, By Chemotherapy Drugs, 2021 - 2031F |
6.1.4 China Anti-Cancer Drug Market Revenues & Volume, By Immunotherapy Drugs, 2021 - 2031F |
6.1.5 China Anti-Cancer Drug Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F |
6.1.6 China Anti-Cancer Drug Market Revenues & Volume, By Biologic Drugs, 2021 - 2031F |
6.2 China Anti-Cancer Drug Market, By Therapy |
6.2.1 Overview and Analysis |
6.2.2 China Anti-Cancer Drug Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F |
6.2.3 China Anti-Cancer Drug Market Revenues & Volume, By Radiation Therapy, 2021 - 2031F |
6.2.4 China Anti-Cancer Drug Market Revenues & Volume, By Hormone Therapy, 2021 - 2031F |
6.2.5 China Anti-Cancer Drug Market Revenues & Volume, By Stem Cell Therapy, 2021 - 2031F |
6.3 China Anti-Cancer Drug Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 China Anti-Cancer Drug Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 China Anti-Cancer Drug Market Revenues & Volume, By Cancer Research Centers, 2021 - 2031F |
6.3.4 China Anti-Cancer Drug Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.3.5 China Anti-Cancer Drug Market Revenues & Volume, By Homecare Settings, 2021 - 2031F |
7 China Anti-Cancer Drug Market Import-Export Trade Statistics |
7.1 China Anti-Cancer Drug Market Export to Major Countries |
7.2 China Anti-Cancer Drug Market Imports from Major Countries |
8 China Anti-Cancer Drug Market Key Performance Indicators |
8.1 Number of clinical trials for anti-cancer drugs in China |
8.2 Investment in research and development of new anti-cancer drugs |
8.3 Adoption rate of innovative treatment methods in cancer care |
9 China Anti-Cancer Drug Market - Opportunity Assessment |
9.1 China Anti-Cancer Drug Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 China Anti-Cancer Drug Market Opportunity Assessment, By Therapy, 2021 & 2031F |
9.3 China Anti-Cancer Drug Market Opportunity Assessment, By End User, 2021 & 2031F |
10 China Anti-Cancer Drug Market - Competitive Landscape |
10.1 China Anti-Cancer Drug Market Revenue Share, By Companies, 2024 |
10.2 China Anti-Cancer Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here